Awards worth Rs.1.20 crores presented to the Awardees as a small token of our appreciation & eternal gratitude.
Sitaram Jaipuria Foundation organized the prestigious Medical & Healthcare Excellence Awards 2022. This event was organized to recognize the invaluable and inspiring work of the Life Savers across
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time.
Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections.
Dr. V. Mohan, President, Madras Diabetes Research Foundation (MDRF) & Chairman, Dr. Mohan’s Diabetes Specialities Centre, has been ranked and recognised as Tamil Nadu’s topmost scientist-cum-researcher in a list compiled and published by Stanford University, Elsevier BV and SciTech Strategies.
A team from Stanford University along
Boehringer Ingelheim Supports his Call to Recognize ‘June’ as Diabetes Control Month
Dr. V. Mohan, Chairman & Chief Diabetologist Dr. Mohan’s Diabetes Specialities Centre, has made an urgent plea to all diabetes management organisations, institutions and people including doctors, hospitals, clinics, NGOs, Governments, and the public